| Hereditary breast and ovarian cancer: new genes in confined pathways FC Nielsen, T van Overeem Hansen, CS Sørensen Nature Reviews Cancer 16 (9), 599-612, 2016 | 408 | 2016 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 395 | 2017 |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020 | 351 | 2020 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 306 | 2015 |
| Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay B Schmidt-Hansen, J Klingelhöfer, B Grum-Schwensen, A Christensen, ... Journal of Biological Chemistry 279 (23), 24498-24504, 2004 | 217 | 2004 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 191 | 2017 |
| Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014 ALF Carlander, CG Larsen, DH Jensen, E Garnæs, K Kiss, L Andersen, ... European Journal of Cancer 70, 75-82, 2017 | 152 | 2017 |
| BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk AB Spurdle, PJ Whiley, B Thompson, B Feng, S Healey, MA Brown, ... Journal of medical genetics 49 (8), 525-532, 2012 | 127 | 2012 |
| Von Hippel-Lindau disease (vHL) ML Binderup, ML Bisgaard, V Harbud, HU Møller, S Gimsing, ... National clinical guideline for diagnosis and surveillance in Denmark. 3rd …, 2013 | 122 | 2013 |
| Favourable effect of TNF‐α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novoCARD15 mutation Case report N Milman, CB Andersen, A Hansen, T van Overeem Hansen, FC Nielsen, ... Apmis 114 (12), 912-919, 2006 | 107 | 2006 |
| Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families TO Hansen, L Jønson, A Albrechtsen, MK Andersen, B Ejlertsen, ... Breast cancer research and treatment 115, 315-323, 2009 | 86 | 2009 |
| Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing PJ Whiley, M De La Hoya, M Thomassen, A Becker, R Brandão, ... Clinical chemistry 60 (2), 341-352, 2014 | 84 | 2014 |
| Cancer predisposition in mice deficient for the metastasis-associated Mts1 (S100A4) gene C EL Naaman, B Grum-Schwensen, A Mansouri, M Grigorian, ... Oncogene 23 (20), 3670-3680, 2004 | 77 | 2004 |
| The BRCA1 c. 5096G> A p. Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA … S Moghadasi, HD Meeks, MPG Vreeswijk, LAM Janssen, Å Borg, ... Journal of medical genetics 55 (1), 15-20, 2018 | 73 | 2018 |
| Human papillomavirus‐related carcinoma with adenoid cystic‐like features of the sinonasal tract: clinical and morphological characterization of six new cases S Andreasen, JA Bishop, TO Hansen, WH Westra, A Bilde, ... Histopathology 70 (6), 880-888, 2017 | 51 | 2017 |
| Magnetic ordering in diluted kagome antiferromagnetsBasis of a presentation given at Materials Discussion No. 3, 26–29 September, 2000, University of Cambridge, UK. J Frunzke, T Hansen, A Harrison, JS Lord, GS Oakley, D Visser, AS Wills Journal of Materials Chemistry 11 (1), 179-185, 2001 | 46 | 2001 |
| The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping TVO Hansen, AY Steffensen, L Jønson, MK Andersen, B Ejlertsen, ... Breast cancer research and treatment 119, 547-550, 2010 | 41 | 2010 |
| Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study JS Mathiesen, JP Kroustrup, P Vestergaard, M Madsen, K Stochholm, ... Endocrine-Related Cancer 24 (7), L39-L42, 2017 | 36 | 2017 |
| M› rini C M Arumugam, J Raes, E Pelletier, D Le Paslier, T Yamada, DR Mende, ... Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S …, 2011 | 35* | 2011 |
